Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.845 SGD | +3.05% | +3.70% | +19.15% |
Mar. 22 | RHB Upgrades Riverstone to Buy From Neutral, Adjusts Price Target to SG$0.93 From SG$0.74 | MT |
Mar. 07 | Engelhart Commodities in talks to buy smaller rival Trailstone | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+19.15% | 901M | B- | ||
+20.78% | 30.41B | B+ | ||
-7.25% | 2.78B | C+ | ||
-35.87% | 2.93B | B- | ||
+1.85% | 1.98B | B | ||
-11.13% | 1.86B | - | A- | |
-20.88% | 1.51B | - | - | |
-11.11% | 1.35B | B | ||
-0.13% | 1.31B | - | ||
-4.43% | 1.06B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock Riverstone Holdings Limited - Singapore S.E.
- Ratings Riverstone Holdings Limited